Wollscheid Hans-Peter, Biancospino Matteo, He Fahu, Magistrati Elisa, Molteni Erika, Lupia Michela, Soffientini Paolo, Rottner Klemens, Cavallaro Ugo, Pozzoli Uberto, Mapelli Marina, Walters Kylie J, Polo Simona
Fondazione Istituto FIRC di Oncologia Molecolare (IFOM), Milan 20139, Italy.
Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA.
Nat Struct Mol Biol. 2016 Apr;23(4):300-308. doi: 10.1038/nsmb.3187. Epub 2016 Mar 7.
Myosin VI functions in endocytosis and cell motility. Alternative splicing of myosin VI mRNA generates two distinct isoform types, myosin VI(short) and myosin VI(long), which differ in the C-terminal region. Their physiological and pathological roles remain unknown. Here we identified an isoform-specific regulatory helix, named the α2-linker, that defines specific conformations and hence determines the target selectivity of human myosin VI. The presence of the α2-linker structurally defines a new clathrin-binding domain that is unique to myosin VI(long) and masks the known RRL interaction motif. This finding is relevant to ovarian cancer, in which alternative myosin VI splicing is aberrantly regulated, and exon skipping dictates cell addiction to myosin VI(short) in tumor-cell migration. The RRL interactor optineurin contributes to this process by selectively binding myosin VI(short). Thus, the α2-linker acts like a molecular switch that assigns myosin VI to distinct endocytic (myosin VI(long)) or migratory (myosin VI(short)) functional roles.
肌球蛋白VI在内吞作用和细胞运动中发挥作用。肌球蛋白VI信使核糖核酸的可变剪接产生两种不同的亚型,即肌球蛋白VI(短型)和肌球蛋白VI(长型),它们在C末端区域有所不同。它们的生理和病理作用仍然未知。在这里,我们鉴定出一种亚型特异性调节螺旋,命名为α2连接体,它定义了特定的构象,从而决定了人类肌球蛋白VI的靶标选择性。α2连接体的存在在结构上定义了一个新的网格蛋白结合结构域,该结构域是肌球蛋白VI(长型)所特有的,并且掩盖了已知的RRL相互作用基序。这一发现与卵巢癌相关,在卵巢癌中,肌球蛋白VI的可变剪接受到异常调节,外显子跳跃决定了肿瘤细胞迁移中细胞对肌球蛋白VI(短型)的依赖性。RRL相互作用蛋白视紫质神经素通过选择性结合肌球蛋白VI(短型)促进这一过程。因此,α2连接体就像一个分子开关,将肌球蛋白VI分配到不同的内吞(肌球蛋白VI(长型))或迁移(肌球蛋白VI(短型))功能角色中。